Expert-Agreed Practical Recommendations on the Use of Fenfluramine in Developmental and Epileptic Encephalopathies Based on Clinical Experience and Literature Review

Abstract Introduction Fenfluramine (FFA) represents the latest therapeutic option approved for seizure management in Dravet syndrome (DS) and Lennox–Gastaut syndrome (LGS) for patients aged ≥ 2 years. This article provides expert guidance for optimizing FFA therapy to support clinical decision-makin...

Cur síos iomlán

Sonraí bibleagrafaíochta

Príomhchruthaitheoirí:	Vicente Villanueva, Victor Soto-Insuga, Patricia Smeyers, Ángel Aledo-Serrano, Rocío Sánchez-Carpintero, Juan García-Peñas, Antonio Gil-Nagel
Formáid:	Artigo
Teanga:	Inglês
Foilsithe / Cruthaithe:	Adis, Springer Healthcare 2025-02-01
Sraith:	Neurology and Therapy
Ábhair:	Antiseizure medication Epilepsy Fenfluramine Developmental epileptic encephalopathies Dravet syndrome Lennox–Gastaut syndrome
Rochtain ar líne:	https://doi.org/10.1007/s40120-025-00713-1
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!